Angewandte Chemie International Edition · 2019 · 28 citations · 33 references
Life SciencesBiotechnologyMedicinal ChemistryAntimicrobial ResistanceEnzymologyProdrug DesignAntibacterial ResistanceAntibiotic ResistanceConjugation ReactionsEnzymatic Cleavage StrategiesEnzyme InhibitionResistance In Gram-negative BacteriaAntibacterial PropertiesAntibiotic DiscoveryEnzymatic Drug HydrolysisEnzymatic HydrolysisEnzyme-cleavable ProdrugsEscherichia ColiEsterasesNovel Antibacterial Drug Discovery
Antimicrobial drug resistance demands novel approaches for improving the efficacy of antibiotics, especially against Gram-negative bacteria. Herein, we report that conjugating a diglycine (GG) to an antibiotic prodrug drastically accelerates intrabacterial ester-bond hydrolysis required for activating the antibiotic. Specifically, the attachment of GG to chloramphenicol succinate (CLsu) generates CLsuGG, which exhibits about an order of magnitude higher inhibitory efficacy than CLsu against Escherichia coli. Further studies reveal that CLsuGG undergoes rapid hydrolysis, catalyzed by intrabacterial esterases (e.g., BioH and YjfP), to generate chloramphenicol (CL) in E. coli. Importantly, the conjugate exhibits lower cytotoxicity to bone marrow stromal cells than CL. Structural analogues of CLsuGG indicate that the conjugation of GG to an antibiotic prodrug is an effective strategy for accelerating enzymatic prodrug hydrolysis and enhancing the antibacterial efficacy of antibiotics.
33
Frank Schlünzen, Raz Zarivach, J. Harms et al. · Nature · 2001 · 1.1K citations
Supramolecular Nanostructures Formed by Anticancer Drug Assembly
Andrew G. Cheetham, Pengcheng Zhang, Yi‐An Lin et al. · Journal of the American Chemical Society · 2013 · 514 citations · Full text